Last updated on March 2018

Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia


Brief description of study

The combination of mitoxantrone and clofarabine as reinduction therapy will be safe, well tolerated and effective in children, adolescents and young adults with poor risk refractory/relapsed acute leukemia and high grade non-Hodgkin lymphoma (NHL).

Clinical Study Identifier: NCT01842672

Contact Investigators or Research Sites near you

Start Over

Javier Oesterheld, MD

Levine Children's Hospital
Charlotte, NC United States
  Connect »

Mitchell Cairo, MD

New York Medical College
Valhalla, NY United States
  Connect »